Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia
Clinical trial NCT07268430 · COMPLETED
Trial details
- NCT number
- NCT07268430
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-18
- Primary completion
- 2024-12-25
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.